NCT02204761

Proton Beam Re-Irradiation in Thoracic Cancers

Definitive Re-irradiation With Proton Beam Radiotherapy for Patients With Recurrent Thoracic Cancers

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: University of Washington · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Not accepted

Summary

This pilot clinical trial studies proton beam radiation therapy in treating patients with thoracic cancer that has come back and have received prior radiation therapy. Proton beam radiation therapy uses high energy protons to kill tumor cells and may cause less damage to normal tissue.

Detailed description

PRIMARY OBJECTIVES: I. To assess the grade 3 toxicity associated with thoracic re-irradiation with proton therapy, with prospectively applied normal organ radiation dose limits. SECONDARY OBJECTIVES: I. To assess the efficacy of thoracic re-irradiation with proton therapy. OUTLINE: Patients undergo proton beam radiation therapy per standard of care. After completion of study treatment, patients are followed up at 3 months.

Conditions

• Metastatic Malignant Neoplasm in the Lung
• Recurrent Disease
• Thoracic Neoplasm

Interventions

Type	Name	Description
RADIATION	Proton Beam Radiation Therapy	Undergo proton beam re-irradiation therapy

Timeline

• Start date: 2014-09-09
• Primary completion: 2017-09-07
• Completion: 2017-09-07
• First posted: 2014-07-30
• Last updated: 2018-11-20
• Results posted: 2018-11-20

Locations

2 sites across 1 country: United States